Welcome to MS Views and News blog

MS Views and News, empowers those affected by Multiple Sclerosis (MS) with educational information, resources and services. Please scroll downward to find articles or videos of interest, then click to open the document or video.

Categories

Latest Blog Posts

October 28, 2010

A comprehensive overview of the eight FDA-approved disease-modifying therapies used to slow MS activity (including the newly approved oral therapy, Gilenya), and initial findings on many of the experimental treatments in development for the treatment of MS

  • MS Drug Therapies
    /
  • Multiple Sclerosis
    /
  • Oral MS Medications
    /
Information provided by: Cherie C. Binns RN BS MSCN From the MS Association of America’s Motivator Summer/Fall 2010 issue Based on…
MS Drug Therapies

October 27, 2010

MS Patients Find Comfort, Flexibility In Yoga

  • Alternative therapies and devices for Multiple Sclerosis (MS)
    /
Experts say with the right supervision, exercise can help manage symptoms of multiple sclerosis, and a special Staten Island yoga…
Alternative therapies and devices for Multiple Sclerosis (MS)

October 27, 2010

MSF Cruise For a Cause® CELEBRATES ITS 10TH YEAR OF CRUISING ABOARD THE OASIS OF THE SEAS

  • News from the MS Foundation
    /
This is a promotion for the MS Foundation’s Cruise for a Cause. The largest and most revolutionary cruise ship in…
News from the MS Foundation

October 26, 2010

Early Treatment With Glatiramer Acetate Improved Outcomes in CIS (Clinically Isolated Syndrome)

  • MS Drug Therapies
    /
  • Multiple Sclerosis
    /
October 25, 2010 By: SHARON WORCESTER, Internal Medicine News Digital Network Patients with clinically isolated syndrome who receive early treatment…
MS Drug Therapies

October 26, 2010

Sanofi-aventis Initiates Phase III Study with Teriflunomide as Adjunct Therapy with Interferon Beta to Further Explore Clinical Benefits in Multiple Sclerosis

  • MS Research Study and Reports
    /
  • Multiple Sclerosis
    /
  • Oral MS Medications
    /
October 26, 2010 TERACLES is the First Phase III Study of an Oral Drug as an Add-On to Standard Therapy…
MS Research Study and Reports

October 25, 2010

Help US to Keep YOUR information Up-to-date, so that you do not miss-out on the MS information we provide

  • For the Benefit of the Patient
    /
  • Multiple Sclerosis
    /
Dear MS Friends,  We are constantly trying to find ways to improve our services and to stay up-to-date with our…
For the Benefit of the Patient

October 25, 2010

DATA FURTHER SUPPORTING ANTI-JC VIRUS ANTIBODY ASSAY PRESENTED AT THE 26TH CONGRESS OF THE European Committee for Treatment and Research in Multiple Sclerosis

  • MS Research Study and Reports
    /
  • Multiple Sclerosis
    /
  • Tysabri
    /
–  Studies support potential of assay to stratify risk of PML in TYSABRI-treated patients – Gothenburg, Sweden – October 16, 2010…
MS Research Study and Reports

October 25, 2010

National Neurological Diseases Surveillance System Act

  • Multiple Sclerosis
    /
Information provided by Cherie C. Binns RN BS MSCN Late last night, the House of Representatives passed H.R. 1362, the National…
Multiple Sclerosis

October 22, 2010

Clues on inflammation in central nervous system uncovered

  • MS Research Study and Reports
    /
  • Multiple Sclerosis
    /
London, Oct 22 : Scientists have found a type of cell that may limit inflammation in the central nervous system…
MS Research Study and Reports

October 22, 2010

A Reason for why UTI’s are more common in women then men?

  • Multiple Sclerosis
    /
  • Symptoms
    /
I learned today that most women, when they sit to pee, they sit hunched forward. This position does not allow…
Multiple Sclerosis

Categories

Latest Blog Posts